Minerva Neurosciences (NERV)
(Delayed Data from NSDQ)
$2.63 USD
+0.04 (1.54%)
Updated Aug 23, 2024 03:06 PM ET
After-Market: $2.64 +0.01 (0.38%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth B Momentum C VGM
Earnings News For NERV
-
Minerva Neurosciences: Q2 Earnings Snapshot
-
Minerva Neurosciences Reports Second Quarter 2024 Financial Results and Business Updates
-
Minerva Neurosciences: Q1 Earnings Snapshot
-
Minerva Neurosciences Reports First Quarter 2024 Financial Results and Business Updates
-
Minerva Neurosciences: Q4 Earnings Snapshot
-
Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Business Updates
-
Minerva Neurosciences: Q3 Earnings Snapshot
-
Minerva Neurosciences Reports 2023 Third Quarter Financial Results and Business Updates
-
Minerva Neurosciences: Q2 Earnings Snapshot
-
Minerva Neurosciences Reports 2023 Second Quarter Financial Results and Business Updates
-
Minerva Neurosciences: Q1 Earnings Snapshot
-
Minerva Neurosciences Reports 2023 First Quarter Financial Results and Business Updates
-
Minerva Neurosciences: Q4 Earnings Snapshot
-
Minerva Neurosciences Reports Fiscal Year 2022 Fourth Quarter And Year End Financial Results And Business Updates
-
Minerva Neurosciences to Report Fiscal Year 2022 Financial Results and Business Updates on March 8, 2023
-
Minerva Neurosciences: Q3 Earnings Snapshot
-
Minerva Neurosciences Reports Third Quarter 2022 Financial Results and Business Updates
-
Minerva Neurosciences: Q2 Earnings Snapshot
-
Minerva Neurosciences Reports Second Quarter 2022 Financial Results and Business Updates
-
Minerva Neurosciences (NERV) Reports Q4 Loss, Misses Revenue Estimates
-
Minerva Neurosciences (NERV) Reports Q3 Loss, Misses Revenue Estimates
-
Minerva Neurosciences (NERV) Reports Q2 Loss, Lags Revenue Estimates
-
Analysts Estimate Minerva Neurosciences (NERV) to Report a Decline in Earnings: What to Look Out for